A delay in drug approvals in the US market remains a concern for Aurobindo. The company stated that eight ANDAs (abbreviated ...

Telangana: Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma, has received an Establishment ...

Curateq Biologics, a wholly owned subsidiary of Aurobindo Pharma, has allotted 4,125,055 Compulsory Convertible Preference Shares (CCPSs) of Rs.10/- each to Dr. Satakarni Makkapati on 20 March 2025.

The company isn't content with just one area of focus; it's actively expanding into new verticals like injectables, peptides, ...

Aurobindo Pharma Ltd - Allotment Of Compulsory Convertible Preference Shares To Dr. Satakarni Makkapati By Curateq Biologics Private Limited, A Wholly Owned Subsidiary Of The Company.

Hyderabad: Nearly a year and a half after its subsidiary, Auro Vaccines Pvt Ltd, inked a licensing pact with Hilleman ...

Aurobindo Pharma rose 1.82% to Rs 1,157.90 after its subsidiary, Apitoria Pharma, received an establishment inspection report (EIR) from the U.S. Food and Drug Administration for its active ...

On March 13, 2025, the Federal Circuit decided in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (No. 2023-2254) how ...

February 6, 2025 India's Aurobindo Pharma posts third-quarter profit drop on higher expenses Indian drugmaker Aurobindo Pharma reported a lower third-quarter profit on Thursday, as a spike in ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Aurobindo Pharma Ltd - Classification Of US FDA Inspection At Unit V Of Apitoria Pharma Private Limited, A Wholly Owned Subsidiary Of The Company - Reg., Intimation of classification of US FDA ...